Following MPI KD (Supplementary Fig. 9a, b), FLT3ITD primary AML MNC were sensitized to FLT3-TKI therapy and this could be rescued by mannose (Fig. 7a). This evidence concerns the gene FLT3 and acute myeloid leukemia.